Sean Maduck

2021

In 2021, Sean Maduck earned a total compensation of $4.5M as Chief Commercial Officer at Corcept Therapeutics, a 42% increase compared to previous year.

Compensation breakdown

Bonus$309,375
Option Awards$3,716,355
Salary$519,451
Total$4,545,181

Maduck received $3.7M in option awards, accounting for 82% of the total pay in 2021.

Maduck also received $309.4K in bonus and $519.5K in salary.

Rankings

In 2021, Sean Maduck's compensation ranked 2,918th out of 12,415 executives tracked by ExecPay. In other words, Maduck earned more than 76.5% of executives.

ClassificationRankingPercentile
All
2,918
out of 12,415
77th
Division
Manufacturing
1,163
out of 5,501
79th
Major group
Chemicals And Allied Products
462
out of 2,374
81st
Industry group
Drugs
405
out of 2,095
81st
Industry
Pharmaceutical Preparations
272
out of 1,542
82nd
Source: SEC filing on April 25, 2022.

Maduck's colleagues

We found four more compensation records of executives who worked with Sean Maduck at Corcept Therapeutics in 2021.

2021

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2021

Atabak Mokari

Corcept Therapeutics

Chief Financial Officer

2021

Charles Robb

Corcept Therapeutics

Secretary

2021

Hazel Hunt

Corcept Therapeutics

Chief Scientific Officer

News

In-depth

You may also like